0001209191-20-024231.txt : 20200413 0001209191-20-024231.hdr.sgml : 20200413 20200413171802 ACCESSION NUMBER: 0001209191-20-024231 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200413 FILED AS OF DATE: 20200413 DATE AS OF CHANGE: 20200413 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pontifax Management 4 G.P. (2015) Ltd. CENTRAL INDEX KEY: 0001726334 STATE OF INCORPORATION: L3 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39264 FILM NUMBER: 20789381 BUSINESS ADDRESS: STREET 1: 14 SHENKAR STREET, BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: 46140 BUSINESS PHONE: 972-9-9725617 MAIL ADDRESS: STREET 1: 14 SHENKAR STREET, BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: 46140 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pontifax (Israel) IV, L.P. CENTRAL INDEX KEY: 0001726039 STATE OF INCORPORATION: E9 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39264 FILM NUMBER: 20789382 BUSINESS ADDRESS: STREET 1: 14 SHENKAR STREET, BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: 46140 BUSINESS PHONE: 972-9-9725617 MAIL ADDRESS: STREET 1: 14 SHENKAR STREET, BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: 46140 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pontifax (Cayman) IV L.P. CENTRAL INDEX KEY: 0001726029 STATE OF INCORPORATION: E9 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39264 FILM NUMBER: 20789383 BUSINESS ADDRESS: STREET 1: 4 SHENKAR STREET, BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: 46140 BUSINESS PHONE: 972-9-9725617 MAIL ADDRESS: STREET 1: 4 SHENKAR STREET, BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: 46140 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pontifax (China) IV L.P. CENTRAL INDEX KEY: 0001726030 STATE OF INCORPORATION: E9 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39264 FILM NUMBER: 20789384 BUSINESS ADDRESS: STREET 1: 14 SHENKAR STREET, BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: 46140 BUSINESS PHONE: 972-9-9725617 MAIL ADDRESS: STREET 1: 14 SHENKAR STREET, BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: 46140 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pontifax Late Stage Fund L.P. CENTRAL INDEX KEY: 0001793769 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39264 FILM NUMBER: 20789385 BUSINESS ADDRESS: STREET 1: 14 SHENKAR STREET STREET 2: BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: L3 46140 BUSINESS PHONE: 972-9-9725617 MAIL ADDRESS: STREET 1: 14 SHENKAR STREET STREET 2: BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: L3 46140 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pontifax Late Stage GP Ltd. CENTRAL INDEX KEY: 0001793770 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39264 FILM NUMBER: 20789386 BUSINESS ADDRESS: STREET 1: 14 SHENKAR STREET STREET 2: BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: L3 46140 BUSINESS PHONE: 972-9-9725617 MAIL ADDRESS: STREET 1: 14 SHENKAR STREET STREET 2: BEIT OFEK CITY: HERZLIYA PITUACH STATE: L3 ZIP: L3 46140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Keros Therapeutics, Inc. CENTRAL INDEX KEY: 0001664710 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 HAYDEN AVENUE, SUITE 120 (BLD E) STREET 2: LEDGEMONT TECHNOLOGY CENTER CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-513-8774 MAIL ADDRESS: STREET 1: 99 HAYDEN AVENUE, SUITE 120 (BLD E) STREET 2: LEDGEMONT TECHNOLOGY CENTER CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-04-13 0 0001664710 Keros Therapeutics, Inc. KROS 0001726334 Pontifax Management 4 G.P. (2015) Ltd. 14 SHENKAR STREET, BEIT OFEK HERZLIYA PITUACH L3 46140 ISRAEL 0 0 1 0 0001726039 Pontifax (Israel) IV, L.P. 14 SHENKAR STREET, BEIT OFEK HERZLIYA PITUACH L3 46140 ISRAEL 0 0 1 0 0001726029 Pontifax (Cayman) IV L.P. 14 SHENKAR STREET, BEIT OFEK HERZLIYA PITUACH L3 46140 ISRAEL 0 0 1 0 0001726030 Pontifax (China) IV L.P. 14 SHENKAR STREET, BEIT OFEK HERZLIYA PITUACH L3 46140 ISRAEL 0 0 1 0 0001793769 Pontifax Late Stage Fund L.P. 14 SHENKAR STREET, BEIT OFEK HERZLIYA PITUACH L3 46140 ISRAEL 0 0 1 0 0001793770 Pontifax Late Stage GP Ltd. 14 SHENKAR STREET, BEIT OFEK HERZLIYA PITUACH L3 46140 ISRAEL 0 0 1 0 Common Stock 2020-04-13 4 C 0 1363542 A 1734395 I See footnote Common Stock 2020-04-13 4 C 0 663825 A 844371 I See footnote Common Stock 2020-04-13 4 C 0 737226 A 937735 I See footnote Common Stock 2020-04-13 4 C 0 169307 A 1903702 I See footnote Common Stock 2020-04-13 4 C 0 82425 A 926796 I See footnote Common Stock 2020-04-13 4 C 0 91538 A 1029273 I See footnote Common Stock 2020-04-13 4 C 0 68654 A 68654 I See footnote Common Stock 2020-04-13 4 C 0 163612 A 2067314 I See footnote Common Stock 2020-04-13 4 C 0 88460 A 1015256 I See footnote Common Stock 2020-04-13 4 C 0 79653 A 1108926 I See footnote Common Stock 2020-04-13 4 C 0 36858 A 105512 I See footnote Common Stock 2020-04-13 4 P 0 194203 16.00 A 2261517 I See footnote Common Stock 2020-04-13 4 P 0 94546 16.00 A 1109802 I See footnote Common Stock 2020-04-13 4 P 0 105000 16.00 A 1213926 I See footnote Common Stock 2020-04-13 4 P 0 43750 16.00 A 149262 I See footnote Series A Preferred Stock 2020-04-13 4 C 0 1363542 0.00 D Common Stock 1363542 0 I See footnote Series A Preferred Stock 2020-04-13 4 C 0 663825 0.00 D Common Stock 663825 0 I See footnote Series A Preferred Stock 2020-04-13 4 C 0 737226 0.00 D Common Stock 737226 0 I See footnote Series B-1 Preferred Stock 2020-04-13 4 C 0 169307 0.00 D Common Stock 169307 0 I See footnote Series B-1 Preferred Stock 2020-04-13 4 C 0 82425 0.00 D Common Stock 82425 0 I See footnote Series B-1 Preferred Stock 2020-04-13 4 C 0 91538 0.00 D Common Stock 91538 0 I See footnote Series B-1 Preferred Stock 2020-04-13 4 C 0 68654 0.00 D Common Stock 68654 0 I See footnote Series C Preferred Stock 2020-04-13 4 C 0 163612 0.00 D Common Stock 163612 0 I See footnote Series C Preferred Stock 2020-04-13 4 C 0 88460 0.00 D Common Stock 88460 0 I See footnote Series C Preferred Stock 2020-04-13 4 C 0 79653 0.00 D Common Stock 79653 0 I See footnote Series C Preferred Stock 2020-04-13 4 C 0 36858 0.00 D Common Stock 36858 0 I See footnote Each share of Series A Preferred Stock, Series B-1 Preferred Stock and Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date. The securities are held by Pontifax (Israel) IV, L.P. ("Israel IV"). Pontifax Management 4 G.P. (2015) Ltd. ("Management 4") is the ultimate general partner of Israel IV. As a result Management 4 may be deemed to share voting and dispositive power with respect to the shares held by Israel IV. Management 4 disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. The securities are held by Pontifax (Cayman) IV, L.P. ("Cayman IV"). Management 4 is the ultimate general partner of Cayman IV. As a result Management 4 may be deemed to share voting and dispositive power with respect to the shares held by Cayman IV. Management 4 disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. The securities are held by Pontifax (China) IV, L.P. ("China IV"). Management 4 is the ultimate general partner of China IV. As a result Management 4 may be deemed to share voting and dispositive power with respect to the shares held by China IV. Management 4 disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. The securities are held by Pontifax Late Stage Fund, L.P. ("Late Stage"). Pontifax Late Stage GP Ltd. ("Late Stage GP") is the general partner of Late Stage and the sole shareholder of Late Stage GP is Mr. Shlomo Karako. Pursuant to Strategic Alliance Agreement, dated August 9, 2018, between Late Stage, Israel IV, Cayman IV and China IV (collectively the, "Pontifax IV Funds"), Late Stage invests side-by-side with the Pontifax IV Funds. By virtue of the strategic relationship, Management 4 may be deemed to share voting and dispositive power with respect to the shares held by Late Stage in a manner similar to the voting and investment power with respect to the shares held by each of the Pontifax IV Funds. Each of Management 4 and Late Stage GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. /s/ Keith Regnante, Attorney-in-Fact for Pontifax Management 4 G.P. (2015) Ltd. 2020-04-13 /s/ Keith Regnante, Attorney-in-Fact for Pontifax (Israel) IV L.P. 2020-04-13 /s/ Keith Regnante, Attorney-in-Fact for Pontifax (Cayman) IV L.P. 2020-04-13 /s/ Keith Regnante, Attorney-in-Fact for Pontifax (China) IV L.P. 2020-04-13 /s/ Keith Regnante, Attorney-in-Fact for Pontifax Late Stage Fund, L.P. 2020-04-13 /s/ Keith Regnante, Attorney-in-Fact for Pontifax Late Stage GP Ltd. 2020-04-13